Regulatory News:

Safe Orthopaedics (Paris:SAFOR):

Pursuant to the article 223-16 of the AMF General Regulation, the total number of shares comprising the share capital and the total number of voting rights as of December 31, 2015, is presented as follow:

Date  

Total number of shares of the
Company

  

Total number of voting rights

31/12/2015   13,736,292   18,589,123

About Safe Orthopaedics

Founded in 2010, Safe Orthopaedics is a French medical technology company that develops and markets an innovative range of sterile implants and associated single-use surgical instruments, with the aim of facilitating safer, optimized and lower-cost spinal surgery. By avoiding the reuse of surgical instruments, Safe Orthopaedics reduces the risk of infection, avoids the cumbersome and unreliable logistics of instrument sterilization, and limits hospital costs. Protected by 17 patent families, the SteriSpine™ Kits are CE-marked and FDA cleared; they are already being marketed in 16 countries, in Europe and the United States. They are being rapidly adopted by surgeons throughout the world, with nearly 1,000 procedures performed in 2014 and 1,691 from January 1st until September 30th 2015. The company is based at Eragny-sur-Oise (France), and has 32 employees and a US subsidiary.

For more information, visit: www.SafeOrtho.com